Tarzana Treatment Centers, Inc.

Tarzana Treatment Centers, Inc., a nonprofit community-based behavioral health and primary care provider headquartered in Tarzana, California, receives federal grant funding as a prime recipient and subrecipient across the Departments of Health and Human Services, Veterans Affairs, and allied agencies. The organization operates as an FQHC-look-alike with nearly 1,200 employees across thirteen service sites in Los Angeles County and has delivered integrated substance use disorder treatment, mental health services, and primary medical care since its founding in 1972.

Tarzana's federal footprint is predominantly grant-funded and heavily weighted toward subrecipient awards (67% of 278 total awards). Recent prime grant recipients include the Health Resources and Services Administration (HRSA), which awarded $650,000 on August 1, 2026, under the Health Center Program (CFDA 93.224) to establish a new access point in Woodland Hills, California, expanding primary care and behavioral healthcare services to serve 16,579 unduplicated patients across a 45-ZIP-code service area. The Substance Abuse and Mental Health Services Administration (SAMHSA) has funded multiple five-year projects: a $650,000-equivalent Overdose Treatment Access (OD-TA) project awarded September 30, 2023 (ultimate completion September 29, 2028), which implements training-of-trainers programs for naloxone distribution and opioid overdose education across FQHCs, community clinics, pharmacies, and college campuses; a Certified Community Behavioral Health Clinic (CCBHC) planning, development, and implementation grant awarded September 30, 2022 (ultimate completion September 29, 2026) to create integrated behavioral health and crisis services in the San Fernando Valley; and a Minority AIDS Service Integration project awarded September 30, 2022 (ultimate completion September 29, 2026) providing whole-person integrated care and HIV prevention for men who have sex with men and people who inject drugs. SAMHSA also awarded a Harm Reduction Program grant on May 30, 2022 (ultimate completion May 29, 2025) to expand syringe exchange services and overdose prevention capacity.

The Department of Health and Human Services dominates customer concentration: HRSA accounts for 106 awards, the Centers for Disease Control and Prevention for 75 awards, and SAMHSA for 36 awards combined. The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 22 carries 12 awards worth $7.2 million combined potential value across two indefinite delivery contracts (VA262P0404 with 9 task orders at $2.4 million combined potential value, and VA26215D0192 with 1 task order at $924 thousand). Coverage across the top five customer entities reaches 82% of award count and 89% of combined potential value.

The vendor's recent activity shows a sharp concentration: 116 awards in 2023, declining to 55 in 2024, 12 in 2025, and 2 in 2026. Combined potential value across all awards totals $8.1 million, but combined obligated dollars reach $152.3 million, indicating substantial multi-year grant funding at completion. Only three awards face ultimate completion within the next twenty-four months, presenting limited near-term recompete exposure. As a subrecipient, Tarzana receives pass-through funding from Los Angeles County (which manages multiple HIV prevention, emergency relief, and surveillance programs) and from state entities including the California Department of Health Care Services (State Opioid Response and MHBG/SABG grants). Teaming relationships include New York University on the NIDA Clinical Trials Network (opioid addiction research and treatment translation) and the University of California, Los Angeles (HIV/AIDS medical case management). The organization's capability portfolio centers on outpatient mental health and substance abuse treatment (primary NAICS category), residential treatment, syringe exchange services, harm reduction, naloxone distribution and overdose education, integrated primary care and behavioral health, and HIV/hepatitis prevention and care coordination for medically underserved and racial/ethnic minority populations in Los Angeles County.